KalVista Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Framingham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
KalVista Pharmaceuticals, Inc. has filed 884 SEC EDGAR filings since 29 Dec 2005

SEC filing history

Showing 1-25 of 34 matching filings.

Per page
25
Current page
1
10-Q File 001-36830

Q3-19 10-Q

Filing date
14 Mar 2019
Reporting date
31 Jan 2019
Next action
Verify source filing
10-Q File 001-36830

Q2-19 FORM 10Q

Filing date
14 Dec 2018
Reporting date
31 Oct 2018
Next action
Verify source filing
10-Q File 001-36830

KALV Q1-19 10-Q

Filing date
14 Sep 2018
Reporting date
31 Jul 2018
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .